CD79A and colorectal carcinoma: In our study, Fn-IgA showed higher sensitivity (36.43%) than CA19-9 (20.16%), and anti-Fn-IgA combined with CEA and CA19-9 improved the sensitivity (54.65%) without compromising specificity (96.60%) for CRC detection.